Cell Impact AB (CI) Stock Statistics & Valuation Metrics

Cell Impact AB has a market cap or net worth of kr37.29M. The enterprise value is kr67.10M.

Cell Impact AB has 294,584,750 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cell Impact AB’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -39.64%.

The current PE Ratio of Cell Impact AB is ―. Cell Impact AB’s PEG ratio is ―.

In the last 12 months, Cell Impact AB had revenue of 37.33M and earned -100.43M in profits. Earnings per share was -0.16.

In the last 12 months, operating cash flow was -29.72M and capital expenditures -5.34M, giving a free cash flow of -35.06M billion.

Cell Impact AB pays an annual dividend of ―, resulting in a dividend yield of ―

Cell Impact AB upcoming earnings date is Nov 6, 2025, TBA (Confirmed).

Cell Impact AB as a current ratio of 3.03, with Debt / Equity ratio of 20.54%

In the past 12 months, Cell Impact AB has paid 85.00K in taxes.

Cell Impact AB EV to EBITDA ratio is -13.45, with an EV/FCF ratio of -11.67.

Cell Impact AB has kr955.00K in cash and marketable securities with kr36.02M in debt, giving a net cash position of -kr35.07M billion.

Gross margin is -27.41%, with operating margin of -265.29%, and net profit margin of -269.08%.

The average price target for Cell Impact AB is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell